Skip to main content
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech — Investor Relations & Filings

Ticker · DIM ISIN · FR0013154002 LEI · 52990006IVXY7GCSSR39 PA Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2024-02-16 Director's Dealing
Country FR France
Listing PA DIM

About Sartorius Stedim Biotech

https://www.sartorius.com/en

Sartorius Stedim Biotech is a leading international provider of equipment and services for the biopharmaceutical industry. The company offers integrated solutions that support the entire lifecycle of drug development and manufacturing, from research and development to quality assurance and commercial production. Its comprehensive portfolio includes technologies for filtration, fluid management, fermentation, cell culture, and purification. Key products encompass bioreactors, single-use systems, process filtration equipment, cell culture media, and data analytics software. Sartorius Stedim Biotech enables its customers to develop and manufacture biotech medications, including cell and gene therapies, more efficiently and safely, helping to accelerate the translation of scientific discoveries into patient care.

Recent filings

Filing Released Lang Actions
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Director's Dealing Classification · 1% confidence The document is titled "Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a specific transaction (Subscription of shares) involving a person closely associated with senior management (Chairman of the Board and CEO). This type of filing, reporting insider transactions by directors or executives, directly corresponds to the definition of Director's Dealing (DIRS). The document is short and contains specific transaction details, confirming it is the report itself, not an announcement of a report.
2024-02-16 English
Sartorius Stedim Biotech SA: Notification des transactions effectuées par les personnes exerçant des responsabilités dirigeantes et les personnes qui leur sont étroitement liées
Director's Dealing Classification · 1% confidence The document is titled "Notification des transactions effectuées par les personnes exerçant des responsabilités dirigeantes et les personnes qui leur sont étroitement liées" (Notification of transactions carried out by persons discharging managerial responsibilities and persons closely associated with them). It details a specific transaction (subscription of shares) on 09/02/2024 involving executives (Joachim Kreuzburg and René Faber) and their closely associated legal entity (Sartorius AG). This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The code for this is DIRS.
2024-02-16 French
Sartorius Stedim Biotech: Information on Document Availability
Report Publication Announcement Classification · 1% confidence The document is dated February 16, 2024, and its primary purpose is to announce that the 'Universal Registration Document 2023' is now available and provides a link to access it. The document itself is very short (1909 characters) and does not contain the full financial statements or detailed business review, but rather points to where the main report can be found. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or is available elsewhere should be classified as a Report Publication Announcement (RPA). The Universal Registration Document (URD) is a comprehensive annual filing, but this specific text is merely the announcement of its availability.
2024-02-16 English
Sartorius Stedim Biotech : Communiqué de mise à disposition de documents
Report Publication Announcement Classification · 1% confidence The document is titled "Sartorius Stedim Biotech : Communiqué de mise à disposition de documents" (Announcement of the availability of documents). It explicitly states that the "Document d'Enregistrement Universel 2023" (Universal Registration Document 2023) is now available and provides a link to access it. The document itself is very short (2015 characters) and serves only to announce the publication of a larger report (the URD 2023, which typically contains annual financial data and management discussion). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published classifies as a Report Publication Announcement (RPA).
2024-02-16 French
Document d'Enregistrement Universel 2023 incluant le rapport financier annuel
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-02-15 French
Document d'Enregistrement Universel 2023 incluant le rapport financier annuel
Annual Report (ESEF) Classification · 0% confidence FY 2023
2024-02-15 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.